We assessed associations with primary clinical parameters and the severity of AD pathology, the abundance of AD-related molecules (tau, Aβ and APOE), as well as the expression of DNA damage and unfolded protein response related genes. This evidence concerns the gene MAPT and Alzheimer disease.